Good Pharmacovigilance Practice in the United States and the European Union
The article presents the results of a comparative analysis of Goodpharmacovigilance practices (GVP), developed by experts of the regulatory bodiesof the European Union (EU) and the United States. It is shown that the EU GVP cover almost all possible aspects of pharmacovigilance. It is noted that the...
Saved in:
Main Authors: | V. A. Merkulov, N. D. Bunyatyan, A. P. Pereverzev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2022-06-01
|
Series: | Безопасность и риск фармакотерапии |
Subjects: | |
Online Access: | https://www.risksafety.ru/jour/article/view/318 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Differences between the European and Eurasian Good Pharmacovigilance Practices
by: A. V. Matveev, et al.
Published: (2021-07-01) -
Changes to the EAEU Guideline on Good Pharmacovigilance Practices
by: B. K. Romanov
Published: (2023-03-01) -
Pharmacovigilance System Master File: An Overview of Changes in the EAEU Good Pharmacovigilance Practice
by: N. Yu. Velts, et al.
Published: (2023-03-01) -
Preparation for the Inspection of the Pharmacovigilance System
by: B. K. Romanov
Published: (2021-10-01) -
Rate Setting for Labour Costs Related to Pharmacovigilance System Inspections
by: M. Abdrakhmanov, et al.
Published: (2022-04-01)